ÂÜÀòÂÒÂ×

Elodie Pronier is an accomplished professional in the fields of biomedical discovery and oncology research. Currently serving as Head of Biomedical Discovery at Owkin since April 2019, Elodie has held various roles, including Co-Director of Biomarker and Target ID and Lead Biologist-Preclinical Program Leader, where responsibilities include leading biological validation pipelines, managing mesothelioma projects, and enhancing collaboration with CROs and academic partners. Prior experience includes a significant tenure at Memorial Sloan Kettering Cancer Center, where Elodie was a Scientist/Project Leader and engaged in national and international collaborations, and at Institut Gustave Roussy as a PhD student managing research on TET2 functions. Elodie's education includes a PhD in Oncology and Hematology from Université Paris Cité and multiple degrees in Genetics and Biology.